Cell - Redefining Clinical Trials: The Age of Personalized Medicine
Links shared publicly online about this topic.
- 0total visits
Cell - Redefining Clinical Trials: The Age of Personalized Medicine
cell.com —
View full resource at cell.com
Tags: Clinical Trial, Personalized Medicine, Genentech, Medical, Medicine
Most Recently Shared on March 21, 2012 at 3:31 pm By:
Genentech VPs Lutzker & Mellman on Redefining #ClinicalTrials: The Age of Personalized #Medicine | via @CellCellPress http://t.co/cv3U4xaX
Pfizer Wins Approval For Xalkori, Lung Cancer Drug That Heralds Age Of Expensive, Personalized Medicines - Yahoo! News
news.yahoo.com — “Read 'Pfizer Wins Approval For Xalkori, Lung Cancer Drug That Heralds Age Of Expensive, Personalized Medicines' on Yahoo! News. Pfizer announced that the Food and Drug Administration has approved Xalkori, generically known as crizotinib, a new medicine that can have a dramatic impact in a small minority of lung cancer patients.The drug will come with a high financial cost to society. Pfizer says it will cost $9,600 a month, or $115,000 for patients who take it for a year. In clinical trials, the” View full resource at news.yahoo.com
Most Recently Shared on August 26, 2011 at 11:15 pm By:
Pfizer Wins Approval For Xalkori, Lung Cancer Drug That Heralds Age Of Expensive, Personalized Medicines: Pfize... http://t.co/DK6PkJY
Delivering Personalized Medicine for Cancer | Focus on Cancer
penn-medicine-focus-on-cancer.blogspot.com — “Penn Medicines Focus on Cancer blog discusses a variety of cancer-related topics, including treatment advances, research efforts and clinical trials, nutrition, support groups, survivorship and patient stories.” View full resource at penn-medicine-focus-on-cancer.blogspot.com
Most Recently Shared on June 16, 2011 at 8:53 pm By:
Penn Medicine Healthcare System
#Cancer Researchers profile cancer cells to develop personalized treatments for #melanoma. http://ht.ly/5jFcC
Advanced Cell Technology Receives FDA Clearance For Clinical Trials Using Embryonic Stem Cells to Treat Age-Related Macular Degeneration | Business Wire
businesswire.com — “Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a leader in the field of regenerative medicine, announced today that the US Food and D” View full resource at businesswire.com
Most Recently Shared on January 3, 2011 at 2:14 pm By:
eyeonfda Pharma and Health Lawyer
Adv Cell Technology Gets FDA Ok 4 Cl Trials Using Embryonic Stem Cells to Treat Age-Related Macular Degeneration - http://ow.ly/3xmAO
Adapt 2009 - Accelerating Development & Advanceing Personalized Therapy - Cambridge Healthtech Institute
adaptcongress.com — “CHI’s ADAPT 2009: Accelerating Development & Advancing Personalized Therapy (September 22-25, 2009, in Washington, DC) focuses on advances in biomarkers, personalized medicine, clinical trials and cancer therapies. Topics include biomarkers in clinical pharmacology, biomarker validation, adaptive clinical trial design, pharmacogenomics and patient stratification, cancer drug targets and pathways, circulating tumor cells, biomarker data analysis and protein biomarkers.” View full resource at adaptcongress.com
Most Recently Shared on August 28, 2009 at 5:25 pm By:
Cambridge Healthtech Institute ADAPT Congress 2009 is on Sept. 22-25, 2009 at Grand Hyatt Washington, Washington, DC http://tiny.cc/U1guZ
Advertisement
